Sandra P. D'Angelo, MD

Pictured: Sandra D’Angelo

Medical oncologist Sandra D’Angelo, who specializes in caring for patients with rare cancers such as melanoma, soft tissue sarcoma, and Merkel cell carcinoma, talks about the team approach and the importance of empowering patients.


I am a medical oncologist specializing in the care of patients with soft tissue and bone sarcoma and merkel cell carcinoma. I work very closely with our multidisciplinary team of medical oncologists, surgeons, radiation oncologists, nurses, and patient support advocates to provide the best care and treatment for patients with these diseases. Our highly specialized team recognizes and appreciates the unique challenges that confront our patients, and we are all committed to addressing their needs.

I hope to develop innovative ways to use the immune system to treat these rare cancers. Immunotherapy has proven to be successful in other cancers such as melanoma, kidney cancer and lung cancer. There are many drugs now available that work to enhance the body’s immune system to attack the cancer. In addition, there has been a great deal of progress using gene therapy to target cancer cells. This work involves the genetic manipulation of patients' immune cells to recognize and kill their own cancer cells. Exploring these avenues has the potential to make immunotherapy a real option for our patients with sarcoma and merkel cell carcinoma.

Appointments for New Patients
Clinical Expertise

Sarcomas of Soft Tissue and Bone; Melanomas; Merkel Cell Carcinoma

Languages Spoken
English; Italian

MD, SUNY Downstate Medical Center


NYU Langone Medical Center


Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology

Publications by Sandra P. D'Angelo
Visit PubMed for full listing of Sandra P. D'Angelo journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.